Futuristic armored hero lunges through a red-blue vortex

About this image

A dynamic science fiction poster featuring a sleek, armored character plunging through a swirling red and blue cosmic backdrop. The image conveys high-tech action and a virus-inspired battle, with neon lighting and a sci-fi vibe that matches themes of antivirus heroes and cyberpunk aesthetics.

A high-energy sci-fi poster features a sleek, armored hero wielding twin blue energy blades amid a vivid red blood-cell landscape and purple molecular structures. The dramatic composition, neon lighting, and biotech theme convey an epic battle between virus and antibody, with a bold title line hinting at "Virus" and its anti-body concept.

Comments (89)

• @nametaker · May 11, 2026

  Great image! The first version is good, but I like the final design of the antagonist better, because it stands out more by being structurally different from the environment, which was kind of lacking in the draft version, imo. Although, if taken out of context, the original design of the baddie is quite awesome as well.

• @DavidP · May 11, 2026

  Thanks. I think in hindsight I missed a trick by not adding an actors name and the fine print on the bottom of a typical movie poster

• @bleepunc · May 11, 2026

  Personally I like the second one. But I am curious on what your consideration to pick the first one

• @DavidP · May 14, 2026

  Thanks. Not so original and really needed more of the actors and fine details.

• @JMN · May 17, 2026

  A big job for a lil guy. I loved the concept when I saw this in voting.

• @DavidP · May 11, 2026

  Thanks - I thought the figure looked a bit wonky in the first attempt

• @breljoset · May 11, 2026

  This was really good, I loved it, got my vote several times

• @panos · May 12, 2026

  This is an absolutely fantastic poster for a great SF concept, David!!

• @archangeltara · May 11, 2026

  Both are awesome I think I like the 2nd one better

• @DavidP · May 11, 2026

  Thanks. I thought his lower body looked a bit wonky in 2.

Sign in to join the conversation.